
Rick Byrd, executive vice president and president of BD's Interventional Segment, announced his retirement after nearly 25 years with the company. Byrd has held multiple leadership roles at BD, contributing to key advancements in medical technology and operational growth, including efforts during the COVID-19 pandemic. He will remain in his role through June, with BD planning to appoint a successor before his departure. His retirement marks a significant leadership transition for the global medical technology firm.